Long-Acting Injectable Antipsychotics (LAIs) Prescribing Trends during the COVID-19 Pandemic in Romania

Long acting injectable antipsychotics (LAIs) are considered the ideal treatment for schizophrenia, especially for young patients with high rates of non-adherence. In the current COVID-19 pandemic, it has been reported that the administration of LAIs decreased in some areas. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Miron, Ana A., Ifteni, Petru I., Teodorescu, Andreea, Petric, Paula S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316377/
https://www.ncbi.nlm.nih.gov/pubmed/35885792
http://dx.doi.org/10.3390/healthcare10071265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316377/
https://www.ncbi.nlm.nih.gov/pubmed/35885792
http://dx.doi.org/10.3390/healthcare10071265

Ejemplares similares